Article Details
Retrieved on: 2023-01-06 12:17:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
2023-01-06 | NYSE:PFE) U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer's 20-Valent Pneumococcal ...
Article found on: stockhouse.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here